Chardan Healthcare Acquisition 2 Corp.

Status: Deal Closed
U=S+W W=S/2@11.5
IPO Proceeds, $M $86.23M
IPO Date Apr 24, 2020
CEO Jonas Grossman
Left Lead Chardan
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Healthcare in North America

IPO Geography US/Canada
Target Company Renovacor Inc
Deal Announced Mar 23, 2021
Deal Size, $M $84.60M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote Sep 1, 2021
Amendment Vote TBD
Closing Date Sep 2, 2021
Formerly CHAQ RCOR RCOR/W

Sign up for Free Trial

No credit card required

Sign in for more on Chardan Healthcare Acquisition 2 Corp.:

  • Structure and cap table
  • 9 directors & officers
  • 19 filings and events
  • 2 underwriters
  • 2 deal advisors
  • 3 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Gbola Amusa 45 Executive Chairman of the Board & Chief Science Officer
Jonas Grossman 45 President, CEO & Director
George Kaufman 42 CFO, Head of Strategy & Director
Guy Barudin 59 COO
Isaac Manke 42 Director
Michael Rice 53 Director
Richard Giroux 46 Director
Matthew Rossen 41 Director
R.A. Session II 41 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Chardan BR 8,450,000 units
B. Riley FBR 50,000
8,500,000 units
Up-Front UW fee 0.58 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 19 filings.

Shareholders

Sign in to view shareholders 13F filing data.